Stalevo (Carbidopa / Levodopa / Entacapone) - Current Clinical Trials

Stalevo Related Clinical Trials

Study to Evaluate Initiation of Stalevo in Early Wearing-Off [Completed]

Stalevo in Early Wearing-Off Patients [Active, not recruiting]

PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding [Terminated]

Pharmacokinetic Study With Repeated Doses of Stalevo [Completed]

Adherence of Stalevo, Entacapone and Levodopa [Completed]

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy [Active, not recruiting]

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-Motor Symptoms in Patients With Idiopathic Parkinson's Disease [Recruiting]

An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN) [Completed]

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa [Completed]

Evaluating Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease [Active, not recruiting]

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-Dose Wearing Off [Recruiting]

Efficacy of Levodopa/Carbidopa/Entacapone vs. Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing Off [Active, not recruiting]